CD69 and cancer: CD69 upregulation by Jurkat cells expressing MC.27.759S or MC.7.G5 TCRs in response to 4 different cancer cells was enhanced by the presence of CD8-αα or CD8-αβ (Figure 2E), with similar levels of CD69 seen for CD8-αα or CD8-αβ.